docetaxel anhydrous has been researched along with 2-naphthol in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (2-naphthol) | Trials (2-naphthol) | Recent Studies (post-2010) (2-naphthol) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 4,120 | 16 | 1,458 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahl, A; Biernacka, KM; Gillatt, D; Holly, JM; Perks, CM; Persad, RA; Uzoh, CC; Zeng, L | 1 |
1 other study(ies) available for docetaxel anhydrous and 2-naphthol
Article | Year |
---|---|
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2.
Topics: Acetylation; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hyperglycemia; Insulin-Like Growth Factor Binding Protein 2; Male; Naphthols; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Sirtuin 1; Sirtuin 2; Taxoids | 2013 |